Pharma New

Chugai Pharmaceutical Co., Ltd.  announced that latest data from an ongoing Japanese phase I/II study (ACE002JP) of emicizumab was presented at the World Federation of Hemophilia 2016 (WFH 2016) World Congress in Orlando, Florida, United States. Emicizumab is a bispecific antibody for subcutaneous injection under development for hemophilia A.

In addition to treating depression, a commonly used antidepressant medication also protects against compounds that can cause memory loss and dementia, new research has found.

Using genomic analysis, researchers have found that a woman in Liberia contracted the deadly Ebola virus early this year after having sexual intercourse with a male survivor of the disease.

Philips India and Ion Beam Applications S.A. (IBA), a global leader in proton therapy for the treatment of cancer, signed an exclusive agreement to enhance access to proton therapy in India. The collaboration also enables both organizations to mutually leverage technologies and solutions. Two companies have already signed multiple country-specific collaboration agreements, each optimized for the local market needs.The alliance combines Philips’ expertise and innovative imaging techniques for strengths in proton therapy.